TARPLIN, DOWNS & YOUNG, LLC for ELI LILLY AND COMPANY
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Medicare/Medicaid MMM
H.R. 1839 - Medicaid Services Investment and Accountability Act of 2019 H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act no specific bills, Medicare Part D, Value based purchasing, Medicare Part B, 340B, Medicare coverage & reimbursement, insulin, Senate and Finance Drug bill
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| CHARLOTTE SPEARS IVANCIC | — |
| ELIZABETH T MURRAY | — |
| EMILY H MURRY | — |
| PAMELA SMITH | — |
| JENNIFER B YOUNG | — |
Health Issues HCR
S. 1416 - Affordable Prescriptions For Patients Act of 2019 S. 1895 - Lower Health Care Costs Act H.R. 3 - Lower Drug Costs Now Act S. 2543 - Prescription Drug Pricing Reduction Act S. 3013 - Encouraging Innovative Benefit Design to Lower Costs for Seniors Act S. 3129 - Lower Costs, More Cures Act of 2019 no specific bills, non-interference, dormant therapies, drug shortages, prescription drug access and affordability, transparency, insulin policy, authorized generics, 340B
| Lobbyist | Covered position, as disclosed |
|---|---|
| RAISSA H DOWNS | — |
| MICHELLE P EASTON | — |
| CHARLOTTE SPEARS IVANCIC | — |
| ELIZABETH T MURRAY | — |
| EMILY H MURRY | — |
| PAMELA SMITH | — |
| JENNIFER B YOUNG | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.